Skip to main content

Month: January 2023

AIM ImmunoTech Enters into Pancreatic Cancer Clinical Research Agreements with AstraZeneca and Erasmus Medical Center

Research collaboration will evaluate the potential of AIM’s Ampligen® (rintatolimod) in combination with AstraZeneca’s Imfinzi (durvalumab) for the treatment of pancreatic cancer OCALA, Fla., Jan. 17, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases — including COVID-19, the disease caused by the SARS-CoV-2 virus — today announced it has entered into an external sponsored collaborative clinical research agreement with Erasmus MC and AstraZeneca. Under the agreement, Erasmus MC is planning to perform an investigator-initiated clinical study, entitled “Combining anti-PD-L1 immune checkpoint inhibitor durvalumab with TLR-3 agonist rintatolimod...

Continue reading

Conduent Named a Leader in Inaugural Everest Group PEAK Assessment of Healthcare Customer Experience Management Service Providers

New report identifies Conduent’s strengths across healthcare customer experience management (CXM) value chain from analytics and automation to omnichannel interaction technologies and CXaaS FLORHAM PARK, N.J., Jan. 17, 2023 (GLOBE NEWSWIRE) — Conduent Incorporated (Nasdaq: CNDT), a global technology-led business process solutions company, today announced that the company is recognized as a Leader in Healthcare Customer Experience Management (CXM) in North America PEAK Matrix ® Assessment 2022. The inaugural report from Everest Group provides a definitive framework for assessing the market success and overall capability of service providers based on performance, experiences, ability and knowledge. Of the 19 providers for healthcare CXM evaluated in North America, Conduent ranked a “Leader” in the top three of the highest performing...

Continue reading

Latin Metals Stakes Large Sedimentary Copper Exploration Property in Argentina

Samples 2.4% Copper and 628 ppm VanadiumPlate 1: Outcropping, shale-hosted copper oxide mineralization grading 2.4% copper, Mirador project.Figure 1: Mirador project location in Argentina together with various current and historical project locations (left), and Mirador project claim block together with regional geologyand historical copper occurrences (right)VANCOUVER, British Columbia, Jan. 17, 2023 (GLOBE NEWSWIRE) — Latin Metals Inc. (“Latin Metals” or the “Company”) – (TSXV: LMS) (OTCQB: LMSQF) announces staking of the Mirador Copper project (“Mirador” or the “Property”), totaling 99,000 hectares and located within Salta Province, Argentina. The property is prospective for sediment-hosted copper deposits, and initial reconnaissance has identified outcropping mineralization with one sample grading 2.4% copper and...

Continue reading

Atlis Motor Vehicles Challenges Biden-Harris Admin’s Blueprint to Decarbonize America’s Transportation Sector: More Support Needed for Those in Rural Communities

MESA, Ariz., Jan. 17, 2023 (GLOBE NEWSWIRE) — Atlis Motor Vehicles (Nasdaq: AMV), a vertically integrated electric vehicle technology ecosystem company, and the first battery manufacturer to be fully owned and operated in the US, today released the following statement after the Biden-Harris administration issued the first-ever U.S. National Blueprint for Transportation Decarbonization, developed by the US departments of Energy, Transportation, Housing and Urban Development, and the Environmental Protection Agency outlining plans to decarbonize transportation nationwide. Mark Hanchett, Atlis Motor Vehicles’ Founder and CEO, said: “After reviewing the Blueprint, we believe investments in alternative fuels and hydrogen should be minimized, and more focus should be placed on proven technologies with tremendous growth potential. Additional...

Continue reading

Transocean Ltd. Announces Proposed Private Offering of $1.175 Billion of Senior Secured Notes due 2030

STEINHAUSEN, Switzerland, Jan. 17, 2023 (GLOBE NEWSWIRE) — Transocean Ltd. (NYSE: RIG) announced today that Transocean Inc., its wholly-owned subsidiary has commenced an offering of U.S. $1.175 billion aggregate principal amount of senior secured notes due 2030 (the “Notes”) to eligible purchasers pursuant to Rule 144A/Regulation S. The Notes will be fully and unconditionally guaranteed on a senior unsecured basis by Transocean Ltd. In addition, the Notes will be guaranteed on a senior secured basis by certain of Transocean Inc.’s subsidiaries that guarantee the existing (i) 7.75% Senior Secured Notes due 2024 issued by Transocean Phoenix 2 Limited (the “Thalassa Notes”), (ii) 5.875% Senior Secured Notes due 2024 issued by Transocean Guardian Limited (the “Guardian Notes”), (iii) 6.25% Senior Secured Notes due 2024 issued by Transocean...

Continue reading

Global Diversified Marketing Group Unveils Business Plans for 2023

ISLAND PARK, N.Y., Jan. 17, 2023 (GLOBE NEWSWIRE) — Global Diversified Marketing Group Inc., Delaware corporation (OTC: GDMK) (the “Company”), operates as a diversified holdings company through several divisions with one of its divisions as a global multi-line consumer packaged goods (“CPG”) with branded product lines and another involved with acquiring ecommerce assets as well as private businesses in various verticals and scaling them up. Following a power-packed performance in 2022, Global Diversified Marketing Group is all set to embark on yet another eventful journey in 2023. This year, the company’s primary area of focus will be to acquire and manage diversified portfolio of online businesses across broad range of verticals as well as achieve a senior exchange listing and attract long-term shareholders. The company’s corporate...

Continue reading

Neuronetics Announces Data Confirming Efficacy in Treating Anxious Depression with NeuroStar® Advanced Therapy for Mental Health

Peer-reviewed publication shows NeuroStar TMS as an effective non-drug treatment for depression with comorbid anxiety MALVERN, Pa., Jan. 17, 2023 (GLOBE NEWSWIRE) —  Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced a new peer-reviewed publication in the Journal of Clinical Psychiatry, presenting real-world evidence of the efficacy of NeuroStar Advanced Therapy for adult patients who suffer concurrently from anxiety symptoms and major depressive disorder (MDD), also known as anxious depression. “Not only is NeuroStar proven to effectively treat people with MDD, but it is also proven to specifically help people suffering from anxiety with depression,”...

Continue reading

EXL recognized as ‘Luminary’ in Celent New Business and Underwriting Systems: Global Life Insurance Edition report

EXL Life Digital Suite earns top honors in annual evaluation of life insurance digital transformation partners NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) — EXL [NASDAQ: EXLS], a leading data analytics and digital operations and solutions company, announced it has been recognized as a “Luminary” in the Celent New Business and Underwriting Systems: Global Life Insurance Edition report. Earning a luminary rating in Celent’s bi-annual evaluation of new business and underwriting solutions outside of North America, EXL’s Life Digital Suite excels on both advanced technology and breadth of functionality, according to the report. The Celent report evaluated 15 different technology platforms supporting the automation and digitization of the new business and underwriting processes to lower operating costs and improve the customer experience....

Continue reading

Shockwave Medical Announces Agreement to Acquire Neovasc

Neovasc’s Innovative Reducer System Will Target the Estimated $5 Billion Refractory Angina Market Shockwave Medical Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Full Year 2023 Revenue Guidance SANTA CLARA, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced it has entered into a definitive agreement to acquire Neovasc Inc. (NASDAQ,TSX:NVCN), a company focused on the minimally invasive treatment of refractory angina. The Neovasc Reducer System is a first-of-its-kind technology to address refractory angina. Refractory angina is a chronic condition in which a patient suffers chest pain that cannot be controlled by conventional therapies. It is estimated...

Continue reading

Onfolio Holdings Inc. to Acquire Contentellect Business, a Leading Provider of Content Writing and Link Building Services

WILMINGTON, Del., Jan. 17, 2023 (GLOBE NEWSWIRE) — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW) (the “Company” or “Onfolio”), a holding company that acquires and manages a diversified portfolio of online businesses across a broad range of verticals, today announced that it has entered into an asset purchase agreement (the “Agreement”) with Contentellect Limited (“Contentellect”) to acquire substantially all its business assets for a purchase price of $850,000 of cash at closing. The transaction is expected to close in the first quarter of 2023. Contentellect was launched in 2018 and began as a specialist content writing service for software-as-a-service companies. Today, Contentellect helps small-and medium-sized businesses scale their content with blog writing, link building, and more. The service offering consists of copywriting...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.